The Mobile Receptor Hypothesis: A Global View

  • David A. Jans
Part of the Molecular Biology Intelligence Unit book series (MBIU)


This chapter attempts to put the findings of the previous seven chapters into a wider context and to expand on the implications of the Mobile Receptor Hypothesis. As we have seen in the last three chapters, receptor movement, as well as the “reverse side of the coin,” receptor immobilization, plays a central role in signaling at the level of the membrane in a variety of signal transduction and receptor systems1,2 and thereby in the regulation of cellular processes such as immune responses, differentiation/transformation, cell proliferation/ death, growth, metabolism and motility/metastasis. From a variety of observations in the previous chapters, and in chapters 6 and 7 in particular, it should be clear that there is a body of evidence for the role of the cytoskeleton in modulating membrane protein lateral mobility as well as for the ability of signaling pathways to interact with and regulate other signal transduction cascades through modulation of the lateral mobilities of heterologous membrane components. Both of these aspects will be discussed in some detail below, with the conclusion that signal transduction pathways are able to modulate the lateral movement of heterologous membrane proteins and receptors largely through regulating their respective membrane skeletal/cytoskeletal linkages. Possible pharmacological applications of knowledge of the factors regulating lateral mobility will be discussed in section E.


Adenylate Cyclase Lateral Movement Mobile Fraction Semliki Forest Virus Lateral Mobility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jans DA. The mobile receptor hypothesis revisited: a mechanistic role for hormone receptor lateral mobility in signal transduction. Biochim Biophys Acta 1992; 1113: 271–276.PubMedGoogle Scholar
  2. 2.
    Jans DA, Pavo I. A mechanistic role for polypeptide hormone receptor lateral mobility in signal transduction. Amino Acids 1995; 9: 93–109.Google Scholar
  3. 3.
    Jans DA, Peters R, Zsigo J et al. The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK, renal epithelial cells at physiological temperature. EMBO J 1989; 8 (9): 2431–2438.Google Scholar
  4. 4.
    Jans DA, Peters R, Fahrenholz F. Lateral mobility of the phospholipase-C-activating vasopressin V,-type receptor in A7r5 smooth muscle cells: a comparison with the adenylate cyclase-coupled V2-receptor. EMBO J 1990; 9 (9): 2693–2699.Google Scholar
  5. 5.
    Jans DA, Peters R, Jans P et al. Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK, renal epithelial cells: role of the cytoskeleton. Exper Cell Res 1990; 191: 121–128.Google Scholar
  6. 6.
    Jans DA, Peters R, Fahrenholz F. An inverse relationship between receptor internalization and the fraction of laterally mobile receptors for the vasopressin renal-type V,-receptor; an active role for receptor immobilization in down-regulation? FEBS Lett 1990; 274: 223–226.PubMedGoogle Scholar
  7. 7.
    Jans DA, Peters R, Jans P et al. Vasopressin V2-receptor mobile fraction and ligand-dependent adenylate cyclase-activity are directly correlated in LLC-PK, renal epithelial cells. J Cell Biol 1991; 114 (1): 53–60.PubMedGoogle Scholar
  8. 8.
    Pavo I, Jans DA, Peters R et al. A vasopressin antagonist that binds to the V,-receptor of LLC-PK, renal epithelial cells is highly laterally mobile but does not effect ligand-induced receptor immobilization. Biochim Biophys Acta 1994; 1223: 240–246.PubMedGoogle Scholar
  9. 9.
    Zakharova OM, Rosenkranz AA, Sobolev AS. Modification of fluid lipid and mobile protein fractions of reticulocyte plasma membranes affects agonist-stimulated adenylate cyclase. Application of the percolation theory. Biochim Biophys Acta 1995; 1236: 177–184.PubMedGoogle Scholar
  10. 10.
    Sobolev AS, Rosenkranz AA, Kazarov AR. Interaction of proteins of the adenylate cyclase complex: area-limited mobility of movement along the whole membrane? Analysis with the application of the percolation theory. Biosc Rep 1984; 4: 897–902.Google Scholar
  11. 11.
    Sobolev AS, Kazarov AR, Rosenkranz AA. Application of percolation theory principles to the analysis of interaction of adenylate cyclase complex proteins in cell membranes. Mol Cell Biochem 1988; 81 (1): 19–28.PubMedGoogle Scholar
  12. 12.
    Atlas D, Volsky DJ, Levitzki A. Lateral mobility of beta-receptors involved in adenylate cyclase activation. Biochim Biophys Acta 1980; 597 (1): 64–69.PubMedGoogle Scholar
  13. 13.
    Tolkovsky AM, Levitzki A. Mode of coupling between the 13-adrenergic receptor and adenylate cyclase in turkey erythrocytes. Biochemistry 1978; 17: 3795–3810.PubMedGoogle Scholar
  14. 14.
    Tolkovsky AM, Levitzki, A. Coupling of a single adenylate cyclase to two receptors: adenosine and catecholamine. Biochemistry 1978; 17: 3811–3817.PubMedGoogle Scholar
  15. 15.
    Tolkovsky A, Braun S, Levitzki A. Kinetics of interaction between /3-receptors, GTP-proteins and the catalytic subunit of turkey erythrocyte adenylate cyclase. Proc Natl Acad Sci USA 1982; 79: 213–217.PubMedGoogle Scholar
  16. 16.
    Hanski E, Rimon G, Levitzki A. Adenylate cyclase activation by the ß-adrenergic receptor as a diffusion controlled process. Biochemistry 1979; 18: 846–853.PubMedGoogle Scholar
  17. 17.
    Rimon G, Hanski E, Levitzki A. Temperature dependence of beta receptor, adenosine receptor, and sodium fluoride stimulated adenylate cyclase from turkey erythrocytes. Biochemistry 1980; 19: 4451–4460.PubMedGoogle Scholar
  18. 18.
    Orly J, Schramm M. Fatty acids as modulators of membrane functions; catecholamine-activated adenylate cyclase of the turkey erythrocyte. Proc Natl Acad Sci USA 1975; 72: 3433–3437.PubMedGoogle Scholar
  19. 19.
    Bergman RN, Hechter H. Neurophyseal hormone-responsive renal adenylate cyclase IV. A random-hit matrix model for coupling in a hormone-sensitive adenylate cyclase system. J Biol Chem 1978; 253: 3238–3250.PubMedGoogle Scholar
  20. 20.
    Kwon G, Axelrod D, Neubig RR. Lateral mobility of tetramethylrhodamine (TMR) labelled G protein alpha and beta gamma subunits in NG 108–15 cells. Cell Signal 1994; 6 (6): 663–679.PubMedGoogle Scholar
  21. 21.
    Neubig RR. Membrane organization in G-protein mechanisms. FASEB J 1994; 8: 939–946.Google Scholar
  22. 22.
    Neubig RR, Sklar LA. Subsecond modulation of formyl peptide-linked guanine nucle-otide-binding proteins by guanosine 5’-O-(3thio)triphosphate in permeabilized neutrophils. Mol Pharmacol 1993; 43 (5): 734–740.PubMedGoogle Scholar
  23. 23.
    Brandt DR, Ross EM. Catecholamine-stimulated GTPase cycle; multiple sites of regulation by ß-adrenergic recceptor and Mgt* studied in reconstituted receptor-G, vesicles. J Biol Chem 1986; 261: 1656–1664.PubMedGoogle Scholar
  24. 24.
    Ransnas LA, Insel PA. Subunit dissociation is the mechanism for hormonal activation of the Gs protein in native membranes. J Biol Chem 1988; 263 (33): 17239–17242.PubMedGoogle Scholar
  25. 25.
    Alousi AA, Jasper JR, Insel PA et al. Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J 1991; 5: 2300–2303.Google Scholar
  26. 26.
    Mueller H, Weingarten R, Ransnas LA et al. Differential amplification of antagonistic receptor pathways in neutrophils. J Biol Chem 1991; 266 (20): 12939–12943.PubMedGoogle Scholar
  27. 27.
    Rees AR, Gregoriou M, Johnson P et al. High affinity epidermal growth factor receptors on the surface of A-431 cells have restricted lateral diffusion. EMBO J 1984; 3: 1843–1847.Google Scholar
  28. 28.
    Ballotti R, Lammers R, Scimeca IC et al. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae. EMBO J 1989; 8: 3303–3309.Google Scholar
  29. 29.
    Gadella TW Jr, Jovin TM. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J Cell Biol 1995; 129 (6): 1543–1558.PubMedGoogle Scholar
  30. 30.
    Gilboa L, Ben Levy R, Yarden Y et al. Roles for a cytoplasmic tyrosine and tyrosine kinase activity in the interactions of Neu receptors with coated pits. J Biol Chem 1995; 270 (13): 7061–7067.PubMedGoogle Scholar
  31. 31.
    Weiner DB, Lui J, Cohen JA et al. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 1989; 339: 230–231.PubMedGoogle Scholar
  32. 32.
    Heffetz D, Zick Y. Receptor aggregation is necessary for activation of the soluble insulin receptor kinase. J Biol Chem 1986; 261: 889–894.PubMedGoogle Scholar
  33. 33.
    Giugni TD, Braslau DL, Haigler HT. Electric field-induced redistribution and postfield relaxation of epidermal growth factor receptors on A431 cells. J Cell Biol 1987; 104 (5): 1291–1297.PubMedGoogle Scholar
  34. 34.
    Venkatakrishnan G, McKinnon CA, Pilapil CG et al. Nerve growth factor receptors are preaggregated and immobile on responsive cells. Biochemistry 1991; 30 (11): 2748–2753.PubMedGoogle Scholar
  35. 35.
    Ljungquist-Hoeddelius P, Lirvall M, Wasteson A et al. Lateral diffusion of PDGF-I3 receptor in human fibroblasts. Bioscience Reports 1991; 11 (1): 43–52.Google Scholar
  36. 36.
    Ljungquist P, Wasteson A, Magnusson KE. Lateral diffusion of plasma membrane receptors labelled with either platelet-derived growth factor (PDGF) or wheat germ agglutinin (WGA) in human leukocytes and fibroblasts. Bioscience Reports 1989; 9: 63–73.PubMedGoogle Scholar
  37. 37.
    Yarden Y, Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochem 1987; 26: 1443–1451.Google Scholar
  38. 38.
    Posner RG, Subramanian K, Goldstein B et al. Simultaneous cross-linking by two nontriggering bivalent ligands causes synergistic signaling of IgE Fc epsilon RI complexes. J Immunol 1995; 155 (7): 3601–3609.PubMedGoogle Scholar
  39. 39.
    Menon AK, Holowka D, Webb WW et al. Clustering, mobility, and triggering activity of small oligomers of immunoglobulin E on rat basophilic leukemia cells. J Cell Biol 1986; 102: 534–540.Google Scholar
  40. 40.
    Menon AK, Holowka D, Webb WW et al. Cross-linking of receptor-bound IgE to aggregates larger than dimers leads to rapid immobilization. J Cell Biol 1986; 102: 541–550.PubMedGoogle Scholar
  41. 41.
    Schlessinger J, Webb WW, Elson EL. Lateral motion and valence of Fc receptors on rat peritoneal mast cells. Nature 1976; 264: 550–552.PubMedGoogle Scholar
  42. 42.
    Mao SY, Varin-Blank N, Edidin M et al. Immobilization and internalization of mutated IgE receptors in transfected cells. J Immunol 1991; 146 (3): 958–966.PubMedGoogle Scholar
  43. 43.
    McCloskey MA, Liu ZY, Poo MM. Lateral electromigration and diffusion of Fce receptors on rat basophilic leukemia cells: effects of IgE binding. J Cell Biol 1984; 99 (3): 778–787.PubMedGoogle Scholar
  44. 44.
    Liu SJ, Hahn WC, Bierer BE et al. Intracellular mediators regulate CD2 lateral diffusion and cytoplasmic Ca“ mobiliza-tion upon CD2-mediated T cell activa-tion. Biophys J 1995; 68 (2): 459–470.PubMedGoogle Scholar
  45. 45.
    Chan PY, Lawrence MB, Dustin ML et al. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2. J Cell Biol 1991; 115 (1): 245–255.PubMedGoogle Scholar
  46. 46.
    Carpen O, Dustin ML, Springer TA et al. Motility and ultrastructure of large granular lymphocytes on lipid bilayers reconstituted with adhesion receptors LFA-1, ICAM-1, and two isoforms of LFA-3. J Cell Biol 1991; 115 (3): 861–871.PubMedGoogle Scholar
  47. 47.
    Liu SJ, Golan DE. Mobilization of intracellular free Cad’ upon T cell activation via TCR/CD3 is required to induce a decrease in CD2 lateral mobility in Jurkat T cell membranes. Biophys J 1994; 66: 149a.Google Scholar
  48. 48.
    Liu SJ, Golan DE. Regulation of CD2 lateral mobility by calmodulin and calcineurin in Jurkat T cell membranes. Biophys J 1994; 66: 149a.Google Scholar
  49. 49.
    Duband JL, Nuckolls GH, Ishihara A et al. Fibronectin receptor exhibits high lateral mobility in embryonic locomoting cells but is immobile in focal contacts and fibrillar streaks in stationary cells. J Cell Biol 1988; 107: 1385–1396.PubMedGoogle Scholar
  50. 50.
    Myohanen HT, Stephens RW, Hedman K et al. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J Histochem Cytochem 1993; 41 (9): 1291–1301.PubMedGoogle Scholar
  51. 51.
    Panaotou G, Waterfield MD. The assembly of signalling complexes by receptor tyrosine kinases. Bioessays 1993; 15 (3): 171–177.Google Scholar
  52. 52.
    Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203–212.PubMedGoogle Scholar
  53. 53.
    Noh DY, Shin SH, Rhee SG. Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim Biophys Acta 1995; 1242 (2): 99–113.PubMedGoogle Scholar
  54. 54.
    Yamashita T, Mao SY, Metzger H. Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56“” protein-tyrosine kinase. Proc Natl Acad Sci USA 1994; 91 (23): 11251–11255.PubMedGoogle Scholar
  55. 55.
    Zhang F, Yang B, Odin JA et al. Lateral mobility of Fcy RIIa is reduced by protein kinase C activation. FEBS Lett 1995; 376 (1–2): 77–80.PubMedGoogle Scholar
  56. 56.
    Sarmay G, Rozsnyay Z, Koncz G et al. Interaction of signaling molecules with human Fcy RIIbi and the role of various Fcy RIIb isoforms in B-cell regulation. Immunol Lett 1995; 44 (2–3): 125–131.PubMedGoogle Scholar
  57. 57.
    Apgar JR. Association of the crosslinked IgE receptor with the membrane skeleton is independent of the known signaling mechanisms in rat basophilic leukemia cells. Cell Regul 1991; 2 (3): 181–191.PubMedGoogle Scholar
  58. 58.
    Paolini R, Numerof R, Kinet JP. Phosphorylation/dephosphorylation of high-affinity IgE receptors: a mechanism for coupling/uncoupling a large signaling complex. Proc Natl Acad Sci USA 1992; 89 (22): 10733–10737.PubMedGoogle Scholar
  59. 59.
    Kent UM, Mao SY, Wofsy C et al. Dynamics of signal transduction after aggregation of cell-surface receptors: studies on the type I receptor for IgE. Proc Nati Acad Sci USA 1994; 91 (8): 3087–3091.Google Scholar
  60. 60.
    Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci 1988; 13: 443–447.PubMedGoogle Scholar
  61. 61.
    Schlessinger J. The epidermal growth factor receptor as a multifunctional allosteric protein. Biochemistry 1989; 27: 3119–3123.Google Scholar
  62. 62.
    Yarden Y, Schlessinger J. Self-phosphorylation of epidermal growth factor: evidence for a model of intermolecular allosteric activation. Biochem 1987; 26: 1434–1442.Google Scholar
  63. 63.
    Becker KE, Ishizaka T, Metzger H et al. Surface IgE on human basophils during histamine release. J Exp Med 1973; 138: 394–409.PubMedGoogle Scholar
  64. 64.
    Lawson D, Fewtrell C, Gomperts B et al. Anti-immunoglobulin-induced histamine secretion by rat peritoneal mast cells studied by immunoferritin electron microscopy. J Exp Med 1975; 142 (2): 391–402.PubMedGoogle Scholar
  65. 65.
    Magro AM, Alexander A. Histamine-release–in vitro studies of inhibitory region of dose-response curve. J Immunol 1974; 112: 1762–1765.PubMedGoogle Scholar
  66. 66.
    Griffin FM Jr, Mullinax PJ. Effects of differentiation in vivo and of lymphokine treatment in vitro on the mobility of C3 receptors of human and mouse mononuclear phagocytes. J Immunol 1985; 135 (5): 3394–3397.PubMedGoogle Scholar
  67. 67.
    Griffin Jnr FM, Mullinax PJ. Augmentation of macrophage complement receptor function in vitro. III. C3b receptors that promote phagocytosis migrate within the plane of macrophage plasma membrane. J Med Exp 1981; 154: 291–305.Google Scholar
  68. 68.
    Hermanowski-Vosatka A, Detmers PA, Gotze O et al. Clustering of ligand on the surface of a particle enhances adhesion to receptor-bearing cells. J Biol Chem 1988; 263 (33): 17822–17827.PubMedGoogle Scholar
  69. 69.
    Ross GD, Reed W, Dalzell JG et al. Macrophage cytoskeletal association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes. J Leukoc Biol 1992; 51 (2): 109–117.PubMedGoogle Scholar
  70. 70.
    Detmers PA, Wright SD, Olsen E et al. Aggregation of complement receptors on human neutrophils in the absence of ligand. J Cell Biol 1987; 105: 1137–1145.PubMedGoogle Scholar
  71. 71.
    Pryzwansky KB, Wyatt T, Reed W et al. Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosis. Eur J Cell Biol 1991; 54 (1): 61–75.PubMedGoogle Scholar
  72. 72.
    Goldstein B, Griego R, Wofsy C. Diffusion-limited forward rate constants in two dimensions. Application to the trapping of cell surface receptors by coated pits. Biophys J 1984; 46 (5): 573–586.PubMedGoogle Scholar
  73. 73.
    Vlodaysky I, Fielding PE, Johnson LK et al. Inhibition of low density lipoprotein uptake in confluent endothelial cell monolayers correlates with a restricted surface receptor redistribution. J Cell Physiol 1979; 100 (3): 481–495.Google Scholar
  74. 74.
    Thatte HS, Bridges KR, Golan DE. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells. J Cell Physiol 1994; 160: 345–357.PubMedGoogle Scholar
  75. 75.
    Thatte HS, Bridges KR, Golan DE. ATP depletion causes translational immobilization of cell surface transferrin receptors in K562 cells. J Cell Physiol 1996; 166: 446–452.PubMedGoogle Scholar
  76. 76.
    Tank DW, Fredericks WJ, Barak LS et al. Electric field-induced redistribution and postfield relaxation of low density lipoprotein receptors on cultured human fibroblasts. J Cell Biol 1985; 101 (1): 148–157.PubMedGoogle Scholar
  77. 77.
    Smith PR, Stoner JC, Viggiano SC et al. Effects of vasopressin and aldosterone on the lateral mobility of eptihelial Na’ channels in A6 epithelial cells. J Memb Biol 1995; 147 (2): 195–205.Google Scholar
  78. 78.
    Meier T, Perez GM, Wallace BG. Immobilization of nicotinic acetylcholine receptors on mouse C2 myotubes by agrininduced protein tyrosine phosphorylation. J Cell Biol 1995; 131 (2): 441–451.PubMedGoogle Scholar
  79. 79.
    Grebenkamper K, Tosi PF, Lazarte JE et al. Modulation of CD4 lateral mobility in intact cells by an intracellularly applied antibody. Biochem J 1995; 312 (1): 251–259.PubMedGoogle Scholar
  80. 80.
    Fire E, Zwart DE, Roth MG et al. Evidence from lateral mobility studies for dynamic interactions of a mutant influenza hemagglutinin with coated pits. J Cell Biol 1991; 115: 1585–1594.PubMedGoogle Scholar
  81. 81.
    Ferns M, Deiner M, Hall Z. Agrin-induced acetylcholine receptor clustering in mammalian muscle requires tyrosine phosphorylation. J Cell Biol 1996; 132 (5): 937–944.PubMedGoogle Scholar
  82. 82.
    Roess DA, Niswender GD, Barisas BG. Cytocholasins and colchicine increase the lateral mobility of human chorionic gonadotropin-occupied luteinizing hormone receptors on ovine luteal cells. Endocrinol 1988; 122: 261–269.Google Scholar
  83. 83.
    Roettger BF, Rentsch RU, Hadac EM et al. Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. J Cell Biol 1995; 130: 579–590.PubMedGoogle Scholar
  84. 84.
    Srinivasan Y, Elmer L, Davis J et al. Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature 1988; 333 (6164): 177–180.PubMedGoogle Scholar
  85. 85.
    Woda BA, Woodin MB. The interaction of lymphocyte membrane proteins proteins with the lymphocyte membrane proteins with the lymphocyte cytoskeletal matrix. J Immunol 1984; 133 (5): 27767–2772.Google Scholar
  86. 86.
    Bennett N, Sitaramayya A. Inactivation of photoexcited rhodopsin in retinal rods: the roles of rhodopsin kinase and 48-kDa protein (arrestin). Biochemistry 1988; 27: 1710–1715.PubMedGoogle Scholar
  87. 87.
    Mao SY, Alber G, Rivera J et al. Interaction of aggregated native and mutant IgE receptors with the cellular skeleton. Proc Natl Acad Sci USA 1992; 89 (1): 222–226.PubMedGoogle Scholar
  88. 88.
    Robertson D, Holowka D, Baird B. Cross-linking of immunoglobulin E-receptor complexes induces their interaction with the cytoskeleton of rat basophilic leukemia cells. J Immunol 1986; 136: 4565–4572.PubMedGoogle Scholar
  89. 89.
    Chopra H, Hatfield JS, Chang YS et al. Role of tumor cell cytoskeleton and membrane glycoprotein IRgpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation. Cancer Res 1988; 48: 3787–3800.PubMedGoogle Scholar
  90. 90.
    Jaffe SH, Friedlander F, Matsuzaki F et al. Differential effects of the cytoplasmic domains of cell adhesion molecules on cell aggregation and sorting-out. Proc Natl Acad Sci USA 1990; 87: 3589–3593.PubMedGoogle Scholar
  91. 91.
    Carpen O, Pallai P, Staunton DE et al. Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and alpha-actinin. J Cell Biol 1992; 118: 1223–1234.PubMedGoogle Scholar
  92. 92.
    Burridge K. Substrate adhesions in normal and transformed fibroblasts: organization and regulation of cytoskeletal, membrane, and extracellular matrix components at focal contacts. Cancer Rev 1987; 4: 18–78.Google Scholar
  93. 93.
    Kupfer A, Singer SJ. The specific interaction of helper T-cells and antigen-presenting B cells. IV. Membrane and cytoskeletal reorganizations in the bound T cell as a function of antigen dose. J Exp Med 1989; 170: 1697–1713.PubMedGoogle Scholar
  94. 94.
    Freed BM, Lempert N, Lawrence DA. The inhibitory effects of N- ethylmaleimide, colchicine and cytochalasins on human T-cell functions. Int J Immunopharmacol 1989; 11: 459–465.PubMedGoogle Scholar
  95. 95.
    Barak LS, Webb WW. Diffusion of low density lipoprotein-receptor complex on human fibroblasts. J Cell Biol 1982; 95: 846–852.PubMedGoogle Scholar
  96. 96.
    Poo H, Krauss JC, Mayo-Bond L et al. Interaction of Fc gamma receptor type IIIB with complement receptor type 3 in fibroblast transfectants: evidence from lateral diffusion and resonance energy transfer studies. J Mol Biol 1995; 247 (4): 597–603.PubMedGoogle Scholar
  97. 97.
    Stolpen AH, Golan DE, Pober JS. Tumor necrosis factor and immune interferon act in concert to slow the lateral diffu-sion of proteins and lipids in human endothelial cell membranes. J Cell Biol 1988; 107: 781–789.PubMedGoogle Scholar
  98. 98.
    Polgar K, Yacono PW, Golan DE et al. Immune interferon gamma inhibits translational diffusion of a plasma membrane protein in preimplantation stage mouse embryos: a T-helper 1 mechanism for immunologic reproductive failure. Am J Obstet Gynecol 1996; 174 (1/1): 282–287.PubMedGoogle Scholar
  99. 99.
    Behrisch A, Dietrich C, Noegel AA et al. The actin-binding protein hisactophilin binds in vitro to partially charged membranes and mediates actin coupling to membranes. Biochemistry 1995; 34: 15182–15190.PubMedGoogle Scholar
  100. 100.
    Goldmann WH, Niggli V, Kaufmann S et al. Probing actin and liposome interaction of talin and talin-vinculin complexes: a kinetic, thermodynamic and lipid labeling study. Biochemistry 1992; 31: 7665–7671.PubMedGoogle Scholar
  101. 101.
    Kaufmann S, Kas J, Goldmann WH et al. Talin anchors and nucleates actin filaments at lipid membranes. A direct demonstration. FEBS Lett 1992; 314: 203–205.PubMedGoogle Scholar
  102. 102.
    Isenberg G. Actin binding proteins-lipid interactions. J Muscle Res Cell Moti! 1991; 12: 136–144.Google Scholar
  103. 103.
    Paccaud JP, Reith W, Johansson B et al. Role of internalization signals and receptor mobility. J Biol Chem 1993; 268 (31): 23191–23196.PubMedGoogle Scholar
  104. 104.
    Ishijima SA, Asakura H, Suzuta T. Participation of cytoplasmic organelles in E-rosette formation. Immunol Cell Biol 1991; 69: 403–409.PubMedGoogle Scholar
  105. 105.
    Horwitz A, Duggan K, Buck C et al. Interaction of plasma membrane fibronectin receptor with talin. A trans-membrane linkage. Nature 1986; 320: 531–532.PubMedGoogle Scholar
  106. 106.
    Burridge K, Molony L, Kelly T. Adhesion plaques: sites of transmembrane interaction between the extracellular matrix and the actin cytoskeleton. J Cell Sci Suppl 1987; 8: 211–229.PubMedGoogle Scholar
  107. 107.
    Schlessinger J, Axelrod D, Koppel DE et al. Lateral transport of a lipid probe and labeled proteins on a cell membrane. Science 1977; 195: 307–309.PubMedGoogle Scholar
  108. 108.
    Schlessinger J, Koppel DE, Axelrod D et al. Lateral transport on cell membranes: mobility of concanavalin A receptors on myoblasts. Proc Natl Acad Sci USA 1976; 73: 2409–2413.PubMedGoogle Scholar
  109. 109.
    Pribluda VS, Metzger H. Transmembrane signaling by the high-affinity IgE receptor on membrane preparations. Proc Natl Acad Sci USA 1992; 89 (23): 11446–11450.PubMedGoogle Scholar
  110. 110.
    Henning SW, Meuer SC, Samstag Y. Serine phosphorylation of a 67-kDa protein in human T lymphocytes represents an accessory receptor-mediated signaling event. J Immunl 1994; 152: 4804–4815.Google Scholar
  111. 111.
    Graeser D, Neubig RR. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108–15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. Mol Pharmacol 1993; 43 (3): 434–443.PubMedGoogle Scholar
  112. 112.
    Robinson MS. The role of clathrin, adaptors and dynamin in endocytosis. Curr Opin Cell Biol 1994: 6 (4): 538–544.PubMedGoogle Scholar
  113. 113.
    Fischer-von-Mollard-G, Stahl B, Li C et al. Rab proteins in regulated exocytosis. Trends Biochem Sci 1994; 19 (4): 164–168.Google Scholar
  114. 114.
    Klueppelberg UG, Gates LK, Gorelick FS et al. Agonist regulated phosphorylation of the pancreatic cholecystokinin receptor. J Biol Chem 1991; 266: 2403–2408.PubMedGoogle Scholar
  115. 115.
    Lutz MP, Pinon DI, Gates LK et al. Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cells. J Biol Chem 1993; 268: 12136–12142.PubMedGoogle Scholar
  116. 116.
    Jesaitis AJ, Bokoch GM, Tolley JO et al. Lateral segregation of neutrophil chemotactic receptors into actin-and fodrinrich plasma membrane microdomains depleted in guanyl nucleotide regulatory proteins. J Cell Biol 1988; 107: 921–928.PubMedGoogle Scholar
  117. 117.
    Jesaitis AJ, Tolley JO, Allen RA. Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes. J Biol Chem 1986; 261: 13662–13669.PubMedGoogle Scholar
  118. 118.
    Johansson B, Wymann MP, HolmgrenPeterson K et al. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist. J Cell Biol 1993; 121: 1281–1289.PubMedGoogle Scholar
  119. 119.
    Wallace BG. Regulation of the interaction of nicotinic acetylcholine receptors with the cytoskeleton by agrin-activated protein tyrosine kinase. J Cell Biol 1995; 128: 1121–1129.PubMedGoogle Scholar
  120. 120.
    Bloch RJ, Morrow JS. An unusual betaspectrin associated with clustered acetylcholine receptors. J Cell Biol 1989; 108: 481–494.PubMedGoogle Scholar
  121. 121.
    Tinsley JM, Blake DJ, Zuellig RA et al. Increasing complexity of the dystrophinassociated protein complex. Proc Natl Acad Sci USA 1994; 91: 8307–8313.PubMedGoogle Scholar
  122. 122.
    Ferns M, Deiner M, Hall Z. Agrin-induced acetylcholine receptor clustering in mammalian muscle requires tyrosine phosphorylation. J Cell Biol 1996; 132 (5): 937–944.PubMedGoogle Scholar
  123. 123.
    Nelson WJ, Hammerton RW. A membrane-cytoskeletal complex containing Na’,K’-ATPase, ankyrin, and fodrin in Madin-Darby canine kidney (MDCK) cells. Implications for the biogenesis of epithelial cell polarity. J Cell Biol 1989; 108: 893–902.PubMedGoogle Scholar
  124. 124.
    Nelson WJ, Veshnock PJ. Ankyrin binding to Na’,K’-ATPase and implications for the organization of membrane domains of polarized cells. Nature 1987; 328: 533–536.PubMedGoogle Scholar
  125. 125.
    Palier MS. Lateral mobility of Na,K-ATPase and membrane lipids in renal cells. Importance of cytoskeletal integrity. J Membr Biol 1994; 142 (1): 127–135.Google Scholar
  126. 126.
    Golan DE, Veatch W. Lateral mobility of band 3 in the human erythrocyte membrane studied by fluorescence photobleaching recovery: evidence for control by cytoskeletal interactions. Proc Nati Acad Sci USA 1980; 77: 2537–2541.Google Scholar
  127. 127.
    Tsuji A, Ohnishi, S. Restriction of the lateral motion of Band 3 in the erythrocyte membrane by the cytoskeletal network: dependence on spectrin association state. Biochemistry 1986; 25: 6133–6139.PubMedGoogle Scholar
  128. 128.
    Tsuji A, Kawasaki S, Ohnishi, S et al. Regulation of band 3 mobilities in erythrocyte ghost membrane by protein association and cytoskeletal network. Biochemistry 1988; 27: 7447–7452.PubMedGoogle Scholar
  129. 129.
    Jans DA, Hemmings BA. CAMP-dependent protein kinase activation affects vasopressin V2-receptor number and inter-nalization in LLC-PK, renal epithelial cells. FEBS Lett 1991; 281: 267–271.PubMedGoogle Scholar
  130. 130.
    Sohlemann-P, Hekman-M, Puzicha-M et al. Binding of purified recombinant (3arrestin to guanine-nucleotide-bindingprotein-coupled receptors. Eur J Biochem 1995; 232 (2): 464–472.Google Scholar
  131. 131.
    Lohse MJ, Andexinger S, Pitcher J et al. Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of (3-arrestin and arrestin in the (32-adrenergic receptor and rhodopsin systems. J Biol Chem 1992; 267 (12): 8558–8564.PubMedGoogle Scholar
  132. 132.
    Benovic JC, Kuhn H, Weyand I et al. Functional desensitization of the isolated 3-adrenergic receptor by the (3-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48kDa protein). Proc Natl Acad Sci USA 1987; 84: 8879–8882.PubMedGoogle Scholar
  133. 133.
    Johnson GL, Dhanasekaran N. The G-protein family and their interactions with receptors. Endocrine Reviews 1992; 10 (3): 317–331.Google Scholar
  134. 134.
    Walter RJ, Berlin RD, Pfeiffer JR et al. Polarization of endocytosis and receptor topography on cultured macrophages. J Cell Biol 1980; 86 (1): 199–211.PubMedGoogle Scholar
  135. 135.
    Raff MC, De Petris S. Ligand-induced redistribution of membrane macromolecules: some possible implications for cancer. J Clin Pathol Suppl R Coll Pathol 1974; 7: 31–34.PubMedGoogle Scholar
  136. 136.
    Allison AC, Davies P, De Petris S. Role of contractile microfilaments in macrophage movement and endocytosis. Nature New Biol 1971; 232 (31): 153–155.PubMedGoogle Scholar
  137. 137.
    Dustin P. Microtubules. KG. Berlin: Springer-Verlag GmbH & Co. 1978.Google Scholar
  138. 138.
    Sarndahl E, Bokoch GM, Stendahl O et al. Stimulus-induced dissociation of alpha subunits of heterotrimeric GTPbinding proteins from the cytoskeleton of human neutrophils. Proc Nat] Acad Sci USA 1993; 90: 6552–6556.Google Scholar
  139. 139.
    Leiber D, Jasper JR, Alousi AA et al. Alteration in Gs-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. J Biol Chem 1993; 268: 3833–3837.PubMedGoogle Scholar
  140. 140.
    Macias MJ, Musacchio A, Ponstingl H et al. Structure of the pleckstrin homology domain from 13-spectrin. Nature 1994; 369: 675–677.PubMedGoogle Scholar
  141. 141.
    Wang DS, Shaw R, Winkelmann JC et al. Binding of PH domains of 3-adrenergic receptor kinase and 3-spectrin to WD40/ 3-transducin repeat containing regions of the 3-subunit of trimeric G-proteins. Biochem Biophys Res Commun 1994; 203 (1): 29–35.PubMedGoogle Scholar
  142. 142.
    Salim K, Gout I, Guruprasad L et al. Crystal structure of the pleckstrin homology domain from dynamin. Nat Struct Biol 1994; 1 (11): 782–788.PubMedGoogle Scholar
  143. 143.
    Musacchio A, Gibson T, Rice P et al. The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci 1993; 18 (9): 343–348.PubMedGoogle Scholar
  144. 144.
    Shaw G. Identification of novel pleckstrin homology (PH) domains provides a hypothesis for PH domain function. Biochem Biophys Res Commun 1993; 195 (2): 1145–1151.PubMedGoogle Scholar
  145. 145.
    Gesemann M, Cavalli V, Denzer AJ et al. Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron 1996; 16 (4): 755–767.PubMedGoogle Scholar
  146. 146.
    Denzer A], Gesemann M, Schumacher B et al. An amino-terminal extension is required for the secretion of chick agrin and its binding to extracellular matrix. J Cell Biol 1995; 131 (6/1): 1547–1560.Google Scholar
  147. 147.
    Namba Y, Ito M, Zu Y et al. Human T-cell L-plastin bundles actin filaments in a calcium-dependent manner. J Biochem (Tokyo) 1992; 112: 503–507.Google Scholar
  148. 148.
    Pacaud M, Derancourt I. Purification and further characterization of macrophage 70-kDa protein, a calcium-regulated, actin-binding protein identical to Lplastin. Biochemistry 1993; 32: 3448–3455.PubMedGoogle Scholar
  149. 149.
    Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitisation of the 3-adrenergic receptor function. FASEB J 1990; 4: 2881–2889.Google Scholar
  150. 150.
    Wallace BG. Regulation of agrin-induced acetyl choline receptor aggregation by Cazf and phorbol ester. J Cell Biol 1988; 107: 267–278.PubMedGoogle Scholar
  151. 151.
    Magnusson KE, Gustafsson M, Holmgren K et al. Small intestinal differentiation in human colon carcinoma HT29 cells has distinct effects on the lateral diffusion of lipid (ganglioside GM1) and proteins (HLA class 1, HLA class 2, and neoplastic epithelial antigens) in the apical cell membrane. J Cell Physiol 1990; 143 (2): 381–390.PubMedGoogle Scholar
  152. 152.
    Wallace BG. Staurosporine inhibits agrin-induced acetyl choline receptor phosphorylation and aggregation. J Cell Biol 1994; 125: 661–668.PubMedGoogle Scholar
  153. 153.
    Yahara I, Edelman GM. Modulation of lymphocyte receptor mobility by locally bound concanavalin A. Proc Natl Acad Sci USA 1975; 72: 1579–1583.PubMedGoogle Scholar
  154. 154.
    Schlessinger J, Elson EL, Webb WW et al. Receptor diffusion on cell surfaces modulated by locally bound concanavalin A. Proc Natl Acad Sci USA 1977; 74 (3): 1110–1114.PubMedGoogle Scholar
  155. 155.
    Henis YI, Elson EL. Inhibition of the mobility of mouse lymphocyte surface immunoglobulins by locally bound concanavalin A. Proc Natl Acad Sci USA 1981; 78: 1072–1076.PubMedGoogle Scholar
  156. 156.
    Edelman GM, Yahara I, Wang JL. Receptor mobility and receptor-cytoplasmic interactions in lymphocytes. Proc Natl Acad Sci USA 1973; 70: 1442–1446.PubMedGoogle Scholar
  157. 157.
    Sharar S, Wim RK, Harlan JM. The adhesion cascade and anti-adhesion therapy: an overview. Springer Semin Immunopathol 1995; 16: 359–378.PubMedGoogle Scholar
  158. 158.
    Henis YI, Hekman M, Elson EL et al. Lateral diffusion of 3-receptors in membranes of cultured liver cells. Proc Natl Acad Sci USA 1982; 79: 2907–2911.PubMedGoogle Scholar
  159. 159.
    Merck Index 11, 2796, 9049, 9887, respectively.Google Scholar
  160. 160.
    Bruno S, Ardelt B, Skierski JS et al. Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res 1992; 52 (2): 470–473.PubMedGoogle Scholar
  161. 161.
    Jarvis WD, Turner AJ, Povirk LF et al. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 1994; 54 (7): 1707–1714.PubMedGoogle Scholar
  162. 162.
    Graves J, Lucas S, Cantrell D. The regulation of protein kinase C in T lymphocytes. In: Rees RC, ed. The biology and clinical applications of interleukin-2. Oxford, New York, Tokyo: IRL Press at Oxford University Press, 1990: 82–89.Google Scholar
  163. 163.
    Geleziunas R, Bour S, Wainberg MA. Human immunodeficiency virus type 1-associated CD4 downmodulation. Adv Virus Res 1994; 44: 203–266.PubMedGoogle Scholar
  164. 164.
    Kielian M. Membrane fusion and the alphavirus life cycle. Adv Virus Res 1995; 45: 113–151.PubMedGoogle Scholar
  165. 165.
    Helenius A, Morein B, Fries E et al. Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Natl Acad Sci USA 1978; 75 (8): 3846–3850.PubMedGoogle Scholar
  166. 166.
    Rosenkranz AA, Yachmenev SV, Jans DA et al. Receptor-mediated endocytosis and nuclear transport of a transfecting DNA construct. Exper Cell Res 1992; 199: 323–329.Google Scholar
  167. 167.
    Akhlynina TV, Yachmenev SV, Jans DA et al. The use of internalizable derivatives of chlorin e6 for increasing its photosensitizing activity. Photochem Photobiol 1993; 58: 45–48.PubMedGoogle Scholar
  168. 168.
    Akhlynina TV, Rosenkranz AA, Jans DA et al. Insulin-mediated intracellular targeting enhances the photodynamic activity of chlorin e6. Cancer Res 1995; 55: 1014–1019.PubMedGoogle Scholar
  169. 169.
    Griffin FM Jr, Mullinax PJ. High concentrations of bacterial lipopolysaccharide, but not microbial infection-induced inflammation, activate macrophage C3 receptors for phagocytosis. J Immunol 1990; 145 (2): 697–701.PubMedGoogle Scholar
  170. 170.
    Detmers PA, Powell DE, Walz A et al. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagacytosis. J Immunol 1991; 147 (12): 4211–4217.PubMedGoogle Scholar
  171. 171.
    Vedder NB, Harlan JM. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 1988; 81: 676–682.PubMedGoogle Scholar
  172. 172.
    Siu K, Detmers PA, Levin SM et al. Transient adhesion of neutrophils to endothelium. J Exp Med 1989; 169: 1779–1793.Google Scholar
  173. 173.
    Helenius A, Kartenbeck J, Simons K et al. On the entry of Semliki Forest virus into BHK-21 cells. J Cell Biol 1980; 84: 404–420.PubMedGoogle Scholar
  174. 174.
    Marsh M, Helenius A. Adsorptive endocytosis of Semliki Forest virus. J Mol Biol 1980; 142: 439–454.PubMedGoogle Scholar
  175. 175.
    Gutman O, Danieli T, White JM et al. Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface: correlation between mobility inhibition and inactivation. Biochemistry 1993; 32 (1): 101–106.PubMedGoogle Scholar
  176. 176.
    Henis YI, Herman-Barhom Y, Aroeti B et al. Lateral mobility of both envelope proteins (F and HN) of Sendai virus in the cell membrane is essential for cell-cell fusion. J Biol Chem 1989; 264: 17119–17125.PubMedGoogle Scholar
  177. 177.
    Volsky DJ, Loyter A. Inhibition of membrane fusion by suppression of lateral movement of membrane proteins. Biochim Biophys Acta 1978; 514: 213–224.PubMedGoogle Scholar
  178. 178.
    Zhang F, Schmidt WG, Hou Y et al. Spontaneous incorporation of the glycosyl-phosphatidylinositol-linked protein Thy-1 into cell membranes. Proc Natl Acad Sci USA 1992; 89: 5231–5235.PubMedGoogle Scholar
  179. 179.
    Kooyman DL, Byrne GW, McClellan S. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 1995; 269 (5220): 89–92.PubMedGoogle Scholar

Copyright information

© R.G. Landes Company 1997

Authors and Affiliations

  • David A. Jans
    • 1
  1. 1.John Curtin School of Medical ResearchAustralian National UniversityCanberraAustralia

Personalised recommendations